AW
REGN icon

Avion Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Avion Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Sell
15
-9
-38% -$6.13K ﹤0.01% 627
2026
Q1 		$18K Buy
24
+7
+41% +$5.36K ﹤0.01% 361
2025
Q4 		$13K Buy
17
+4
+31% +$2.72K ﹤0.01% 432
2025
Q3 		$7K Hold
13
– – ﹤0.01% 579
2025
Q2 		$6K Buy
13
+4
+44% +$2.23K ﹤0.01% 594
2025
Q1 		$6K Hold
9
– – ﹤0.01% 512
2024
Q4 		$6K Sell
9
-4
-31% -$3.36K ﹤0.01% 511
2024
Q3 		$13K Buy
13
+2
+18% +$2.23K ﹤0.01% 329
2024
Q2 		$11K Buy
11
+1
+10% +$969 ﹤0.01% 320
2024
Q1 		$10K Buy
10
+4
+67% +$3.8K ﹤0.01% 317
2023
Q4 		$5K Sell
6
-2
-25% -$1.65K ﹤0.01% 408
2023
Q3 		$5K Buy
8
+4
+100% +$3.14K ﹤0.01% 368
2023
Q2 		$2K Buy
+4
New +$3.08K ﹤0.01% 492

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Avion Wealth's REGN Position: Q2 2026 in Review

Avion Wealth reduced its Regeneron Pharmaceuticals (REGN) stake by 38% in Q2 2026, selling an estimated $6.13K and leaving 15 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

Avion Wealth first reported a position in REGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $18K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Avion Wealth held 15 shares of Regeneron Pharmaceuticals worth $9K as of Q2 2026.
  • Avion Wealth sold 9 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.13K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #627 holding.
  • Avion Wealth first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Avion Wealth's Regeneron Pharmaceuticals position peaked at $18K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.